Vivekanandan, S., Breene, R., Ramanujachar, R., Traunecker, H., Pizer, B., Gaze, M. N., Saran, F., Thorp, N., English, M., Wheeler, K., Michalski, A., Walker, D. A., Saunders, D., Cowie, F., Cameron, A., Picton, S., Parashar, D., Horan, G., & Williams, M. V. (2016). reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response‐Directed High‐Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy). Pediatric blood & cancer, 63(6), 1125–1126. http://access.bl.uk/ark:/81055/vdc_100031856620.0x00000a